Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 237

1.

Comparison of the antipsoriatic effect and tolerability of calcipotriol-containing products in the treatment of psoriasis vulgaris using a modified psoriasis plaque test.

Queille-Roussel C, Hoffmann V, Ganslandt C, Hansen KK.

Clin Drug Investig. 2012 Sep 1;32(9):613-9. doi: 10.2165/11634710-000000000-00000.

PMID:
22845045
2.
3.

Treatment of psoriasis vulgaris with the two-compound product calcipotriol/betamethasone dipropionate followed by different formulations of calcipotriol.

Cassano N, Miracapillo A, Coviello C, Loconsole F, Bellino M, Vena GA.

Clin Drug Investig. 2006;26(4):227-33.

PMID:
17163256
4.

Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.

Kragballe K, Noerrelund KL, Lui H, Ortonne JP, Wozel G, Uurasmaa T, Fleming C, Estebaranz JL, Hanssen LI, Persson LM.

Br J Dermatol. 2004 Jun;150(6):1167-73.

PMID:
15214905
5.

Calcipotriol ointment. A review of its use in the management of psoriasis.

Scott LJ, Dunn CJ, Goa KL.

Am J Clin Dermatol. 2001;2(2):95-120. Review.

PMID:
11705309
7.
8.

Use of a psoriasis plaque test in the development of a gel formulation of calcipotriol and betamethasone dipropionate for scalp psoriasis.

Queille-Roussel C, Hoffmann V, Enevold A, Ganslandt C.

J Dermatolog Treat. 2013 Aug;24(4):250-4. doi: 10.3109/09546634.2011.641936.

PMID:
22103604
9.
10.

A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.

van de Kerkhof PC, van der Valk PG, Swinkels OQ, Kucharekova M, de Rie MA, de Vries HJ, Damstra R, Oranje AP, de Waard-van der Spek FB, van Neer P, Lijnen RL, Kunkeler AC, van Hees C, Haertlein NG, Hol CW.

Br J Dermatol. 2006 Oct;155(4):800-7.

PMID:
16965431
11.

Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.

Lahfa M, Mrowietz U, Koenig M, Simon JC.

Eur J Dermatol. 2003 May-Jun;13(3):261-5.

12.

Efficacy of an innovative aerosol foam formulation of fixed combination calcipotriol plus betamethasone dipropionate in patients with psoriasis vulgaris.

Queille-Roussel C, Olesen M, Villumsen J, Lacour JP.

Clin Drug Investig. 2015 Apr;35(4):239-45. doi: 10.1007/s40261-015-0269-7.

13.
16.

Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris.

Kragballe K, Gjertsen BT, De Hoop D, Karlsmark T, van de Kerkhof PC, Larkö O, Nieboer C, Roed-Petersen J, Strand A, Tikjøb G.

Lancet. 1991 Jan 26;337(8735):193-6. Erratum in: Lancet 1991 Apr 20;337(8747):988.

PMID:
1670840
17.

A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.

van de Kerkhof PC, Hoffmann V, Anstey A, Barnes L, Bolduc C, Reich K, Saari S, Segaert S, Vaillant L.

Br J Dermatol. 2009 Jan;160(1):170-6. doi: 10.1111/j.1365-2133.2008.08927.x.

PMID:
19067709
18.

A new calcipotriol/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris.

Kaufmann R, Bibby AJ, Bissonnette R, Cambazard F, Chu AC, Decroix J, Douglas WS, Lowson D, Mascaro JM, Murphy GM, Stymne B.

Dermatology. 2002;205(4):389-93.

PMID:
12444337
19.

Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study.

Fleming C, Ganslandt C, Guenther L, Johannesson A, Buckley C, Simon JC, Stegmann H, Vestergaard Tingleff L.

Eur J Dermatol. 2010 Jul-Aug;20(4):465-71. doi: 10.1684/ejd.2010.0948.

PMID:
20413372
Items per page

Supplemental Content

Support Center